Yizhen Pang

Synthesis, Preclinical Evaluation, and a Pilot Clinical PET Imaging Study of 68Ga-Labeled FAPI Dimer

Zhide Guo, Xianzhong Zhang, Q. Lin, 2021, The Journal of Nuclear Medicine.

68Ga-fibroblast activation protein inhibitor PET/CT on gross tumour volume delineation for radiotherapy planning of oesophageal cancer.

Hua Wu, Q. Lin, Long Sun, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Comparison of 68Ga-FAPI and 18F-FDG PET/CT in a Patient With Cholangiocellular Carcinoma: A Case Report.

Long Sun, Yizhen Pang, Haojun Chen, 2020, Clinical nuclear medicine.

Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer

Hua Wu, Q. Lin, Long Sun, 2020, European Journal of Nuclear Medicine and Molecular Imaging.

Dual Targeting of Integrin αvβ3 and Neuropilin-1 Receptors Improves Micropositron Emission Tomography Imaging of Breast Cancer.

Hua Wu, Zhide Guo, Xianzhong Zhang, 2022, Molecular pharmaceutics.

68Ga-FAPI PET/CT in Assessment of Leptomeningeal Metastases in a Patient With Lung Adenocarcinoma.

Long Sun, Yizhen Pang, Haojun Chen, 2020, Clinical nuclear medicine.

Positron emission tomography/computed tomography-guided percutaneous trans-pararectal space prostate biopsy for the diagnosis of prostate cancer: A retrospective study

Hua Wu, Long Sun, Yizhen Pang, 2019 .

Dual Targeting of Integrin αvβ3 and VEGF Receptor Improves PET Imaging of Breast Cancer

Hua Wu, Zhide Guo, Xianzhong Zhang, 2021 .

Development of Fibroblast Activation Protein Inhibitor-Based Dimeric Radiotracers with Improved Tumor Retention and Antitumor Efficacy.

Hua Wu, Zhide Guo, Xianzhong Zhang, 2022, Molecular pharmaceutics.